CorMedix Correlations
CRMD Stock | USD 10.29 0.19 1.88% |
The current 90-days correlation between CorMedix and Aldeyra is -0.19 (i.e., Good diversification). The correlation of CorMedix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
CorMedix Correlation With Market
Significant diversification
The correlation between CorMedix and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CorMedix and DJI in the same portfolio, assuming nothing else is changed.
CorMedix |
Moving against CorMedix Stock
0.69 | INZY | Inozyme Pharma | PairCorr |
0.48 | XFOR | X4 Pharmaceuticals | PairCorr |
0.47 | EXAS | EXACT Sciences | PairCorr |
0.42 | NTLA | Intellia Therapeutics | PairCorr |
0.4 | NVO | Novo Nordisk AS | PairCorr |
0.36 | FATE | Fate Therapeutics | PairCorr |
0.65 | CTMX | CytomX Therapeutics | PairCorr |
0.62 | TERN | Terns Pharmaceuticals | PairCorr |
0.61 | CRNX | Crinetics Pharmaceuticals Earnings Call Today | PairCorr |
0.51 | BNTC | Benitec Biopharma | PairCorr |
0.43 | CNTA | Centessa Pharmaceuticals | PairCorr |
0.39 | ADTX | Aditxt Inc | PairCorr |
0.38 | CRBU | Caribou Biosciences | PairCorr |
0.37 | REGN | Regeneron Pharmaceuticals | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between CorMedix Stock performing well and CorMedix Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CorMedix's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
TARS | 2.21 | 0.06 | 0.02 | (0.83) | 3.09 | 4.48 | 15.82 | |||
LIAN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ALDX | 2.75 | 0.72 | 0.23 | (0.75) | 2.60 | 6.73 | 20.08 | |||
TVTX | 2.55 | 0.30 | 0.11 | 0.18 | 2.51 | 5.93 | 19.34 | |||
ETON | 3.58 | 0.59 | 0.12 | 1.51 | 4.34 | 7.43 | 25.22 | |||
PGEN | 4.91 | 1.39 | 0.28 | 2.41 | 4.29 | 12.35 | 38.00 | |||
TCRR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
SGMO | 5.41 | (0.43) | 0.00 | (1.00) | 0.00 | 10.31 | 85.68 | |||
APTO | 74.30 | 35.87 | 1.57 | (0.28) | 13.62 | 26.67 | 2,469 | |||
ELYM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CorMedix Corporate Management
Kaufman Esq | Chief EVP | Profile | |
Joseph MBA | CEO Director | Profile | |
Donna Ucci | Senior Quality | Profile | |
Tushar Mukherjee | Senior Operations | Profile | |
Phoebe Esq | Gen EVP | Profile | |
Elizabeth BA | Executive Affairs | Profile | |
Erin Mistry | Executive Officer | Profile |